Coalition Opposes Congressional Attempt to Stifle Lower-Priced Generic Drug Competition

A coalition of policy think tanks sent a letter to Congress warning them that proposed legislation would have severe adverse consequences on consumers by significantly impeding the market entry of generic drug manufacturers. These generic drug companies offer much lower-priced drug for patients because they compete against name brand products — sometimes saving patients 90% […]

ACI Statement Regarding Today’s House Energy and Commerce Committee’s Privacy and Innovation Hearing

Washington, DC, March 29, 2012 — Today’s hearing by the House Energy and Commerce committee is an important first step in making sure that we take a more comprehensive look at protecting consumer privacy in the digital age.  Consumers are growing increasingly concerned about their online privacy and the way in which their privacy is being […]